✦ LIBER ✦

The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones

✍ Scribed by Paul Workman

Publisher: Springer
Year: 2003
Tongue: English
Weight: 495 KB
Volume: 52
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-003-0593-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Personalized medicine and development of

Personalized medicine and development of targeted therapies: the upcoming challenge for diagnostic molecular pathology. A review

✍ Manfred Dietel; Christine Sers 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 360 KB

Retracted: The evolution of predictive o

Retracted: The evolution of predictive oncology and molecular-based therapy for oral cancer prevention

✍ Jon Sudbø; Albrecht Reith 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 518 KB

## Abstract Retraction: The following article from International Journal of Cancer, “The evolution of predictive oncology and molecular‐based therapy for oral cancer prevention”, by Jon Sudbø and Albrecht Reith, published online in Wiley InterScience (http://www3.interscience.wiley.com) on 1 Februa

The role of kinesin family proteins in t

The role of kinesin family proteins in tumorigenesis and progression : Potential biomarkers and molecular targets for cancer therapy

✍ Yue Yu; Yu-Mei Feng 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 2 views

The role of Fas ligand and transforming

The role of Fas ligand and transforming growth factor β in tumor progression : Molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy

✍ Ryungsa Kim; Manabu Emi; Kazuaki Tanabe; Yoko Uchida; Tetsuya Toge 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

## Abstract Despite the fact that expression of Fas ligand (FasL) in cytotoxic T lymphocytes (CTLs) and in natural killer (NK) cells plays an important role in Fas‐mediated tumor killing, During tumor progression FasL‐expressing tumor cells are involved in __counterattacking__ to kill tumor‐infiltr